We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

EP-100 Plus Paclitaxel Versus Paclitaxel Alone in Patients With Ovarian Cancer (ESP2011-002)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01485848
Recruitment Status : Completed
First Posted : December 6, 2011
Last Update Posted : June 10, 2014
Information provided by (Responsible Party):
Esperance Pharmaceuticals Inc

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : May 2014
  Study Completion Date : May 2014